| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2008 | US7316928 Expression vector comprising nucleotide sequences coding fatty acid aminde hydrolase for use in generation of plants with enhanced growth, seed germination, pathogen response and stress tolerance |
| 01/08/2008 | US7316926 Brain capillary cells; culture product |
| 01/08/2008 | US7316925 Codon optimized synthetic plasmids |
| 01/08/2008 | US7316924 Chimeric polypeptides for use as gene expression tool in genetic engineering |
| 01/08/2008 | US7316923 Compositions and methods for non-targeted activation of endogenous genes |
| 01/08/2008 | US7316920 Serine proteases from gram-positive microorganisms |
| 01/08/2008 | US7316916 DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids |
| 01/08/2008 | US7316915 Polypeptide for use in the treatment of apoptitic disorders |
| 01/08/2008 | US7316914 Comprises cassettes derived from regulatory region of methylenomycin gene cluster of Streptomyces plasmid |
| 01/08/2008 | US7316912 Tyrosylprotein sulfotransferases and methods of use thereof |
| 01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |
| 01/08/2008 | CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography |
| 01/08/2008 | CA2331781C De novo dna cytosine methyltransferase genes, polypeptides and uses thereof |
| 01/08/2008 | CA2324244C Device for analyzing a sample |
| 01/08/2008 | CA2324028C Retroviral packaging cell line |
| 01/08/2008 | CA2319777C Dideoxy dye terminators |
| 01/08/2008 | CA2319757C Method for detection of nucleic acid target sequences involving in vitro transcription from an rna promoter |
| 01/08/2008 | CA2271929C Method and apparatus for preparing sample cartridges for a particle acceleration device |
| 01/08/2008 | CA2234656C Modified bacillus thuringiensis gene for lepidopteran control in plants |
| 01/08/2008 | CA2228269C High efficiency helper system for aav vector production |
| 01/08/2008 | CA2225183C Novel foam proteins and use thereof |
| 01/08/2008 | CA2223034C Methods for producing a potentiator of bacillus pesticidal activity |
| 01/08/2008 | CA2210354C Mutant luciferases |
| 01/08/2008 | CA2181841C Transport vehicles for macromolecules |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/08/2008 | CA2163868C Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/08/2008 | CA2128794C Mutant aox2 promoter, vector carrying same, transformant, and production of heterologous protein |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2591804A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2557772A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/04/2008 | CA2551537A1 Method for preparing recombinant mycobacterial polypeptides in yeast and their use in diagnosis of mycobacterial related diseases |
| 01/03/2008 | WO2008002964A2 Grg33, grg35, grg36, grg37, grg38, grg39, and grg50: novel epsp synthase genes conferring herbicide resistance |
| 01/03/2008 | WO2008002962A2 Grg32: a novel epsp synthase gene conferring herbicide resistance |
| 01/03/2008 | WO2008002668A2 Methods for arbitrary peptide synthesis |
| 01/03/2008 | WO2008002472A2 Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties |
| 01/03/2008 | WO2008002470A2 Sirna sequences against brf1 |
| 01/03/2008 | WO2008002400A2 Methods for altering cellular susceptibility to infection |
| 01/03/2008 | WO2008002250A1 Improved stem cells for transplantation and methods for production thereof |
| 01/03/2008 | WO2008002157A1 Apyrases and uses thereof |
| 01/03/2008 | WO2008001947A1 MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME |
| 01/03/2008 | WO2008001944A1 Reagent for detection of autoantibody and kit for diagnosis of autoimmune disease |
| 01/03/2008 | WO2008001912A1 Substituted benzyl ester derivative and use thereof |
| 01/03/2008 | WO2008001903A1 Fad-conjugated glucose dehydrogenase gene |
| 01/03/2008 | WO2008001778A1 Genetically modified animal and use thereof |
| 01/03/2008 | WO2008001700A1 Alkaline phosphatase |
| 01/03/2008 | WO2008001691A1 Method of treating sample |
| 01/03/2008 | WO2008001676A1 Lactic acid bacterium for amelioration of lactose intolerance |
| 01/03/2008 | WO2008001597A1 Method for production of protein |
| 01/03/2008 | WO2008001505A1 Composition for nucleic-acid introduction |
| 01/03/2008 | WO2008001504A1 Composition for nucleic acid delivery |
| 01/03/2008 | WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 01/03/2008 | WO2008001414A1 Cosmid vector for transforming plant and method of using the same |
| 01/03/2008 | WO2008001219A2 Cancer therapy using bcl-xl-specific sina |
| 01/03/2008 | WO2008001156A1 CANCER THERAPY USING BcI-XL-SPECIFIC siNA |
| 01/03/2008 | WO2008001126A2 Compositions and methods relating to cellular targeting |
| 01/03/2008 | WO2008001063A1 Antibody molecules which bind human il-17 |
| 01/03/2008 | WO2008001045A1 Members of the glycoside hydrolase family 31 family of proteins |
| 01/03/2008 | WO2008000881A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 01/03/2008 | WO2008000779A2 Polioma vector expressing long double-stranded rnas |
| 01/03/2008 | WO2008000748A1 Novel bifunctional trehalose synthase |
| 01/03/2008 | WO2008000715A1 High throughput transfection of filamentous fungi |
| 01/03/2008 | WO2008000714A1 Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides |
| 01/03/2008 | WO2008000632A1 A method for achieving improved polypeptide expression |
| 01/03/2008 | WO2008000511A2 Pektin methyltransferases and their applications |
| 01/03/2008 | WO2008000445A1 Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells |
| 01/03/2008 | WO2008000416A1 Biological process using a glucose-6-phosphate isomerase |
| 01/03/2008 | WO2008000415A1 Biological process using a transaldolase |
| 01/03/2008 | WO2008000344A1 Process for isolating nucleic acids |
| 01/03/2008 | WO2008000343A1 Nucleic acid extraction method |
| 01/03/2008 | WO2008000186A1 A method for identifying novel gene and the resulting novel genes |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2008000028A1 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 01/03/2008 | WO2007131699A3 Novel stress-related microrna molecules and uses thereof |
| 01/03/2008 | WO2007129093A3 Hla peptide therapy |
| 01/03/2008 | WO2007127589A3 Artificial disulfide isomerases and uses thereof |
| 01/03/2008 | WO2007112940A3 Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same |
| 01/03/2008 | WO2007102174A3 Process for preparing human g-csf |
| 01/03/2008 | WO2007100584A3 Antiviral agents and vaccines against influenza |
| 01/03/2008 | WO2007090143A3 Soybean isopentenyl transferase genes and methods of use |
| 01/03/2008 | WO2007082105A3 Chlamydia vaccine |
| 01/03/2008 | WO2007081772A3 Taxus transformation, transformed cells, and related compositions and methods |
| 01/03/2008 | WO2007080457A3 Use of inhibitors of scinderin and/or of ephrin-a1 for treating tumors |
| 01/03/2008 | WO2007006581A3 Targeting lsd1 for use in identifying and/or scoring prostate cancer and for controlling anrogen receptor-dependent gene expression |
| 01/03/2008 | WO2006137941A3 Methods and compositions involving mirna and mirna inhibitor molecules |
| 01/03/2008 | WO2006119115A3 Anti-il-6 antibodies, compositions, methods and uses |
| 01/03/2008 | WO2006109174A3 Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid |
| 01/03/2008 | WO2006063082A3 Methods and compositions for modulating apoptotic pathways |
| 01/03/2008 | WO2005079232A3 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK |
| 01/03/2008 | WO2005047505A3 Methods and products for expression of micro rnas |
| 01/03/2008 | WO2005010166A3 P450 oxygenases and methods of use |
| 01/03/2008 | WO2005007196A3 Lipid encapsulated interfering rna |
| 01/03/2008 | WO2004081226A3 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 01/03/2008 | WO2004060323A3 Novel inhibitors of poxvirus replication |
| 01/03/2008 | WO2003085085A3 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| 01/03/2008 | US20080005813 Polypeptide Having Function of Cinnamyl Alcohol Dehydrogenase, Polynucleotide Encoding the Polypeptide and Those Uses |
| 01/03/2008 | US20080005812 Expression cassettes; cells, seeds, plants |
| 01/03/2008 | US20080005811 Pufa polyketide synthase systems and uses thereof |
| 01/03/2008 | US20080005810 Method of conferring multiple stress tolerance and early flowering in plants |
| 01/03/2008 | US20080005808 transgenic plants transformed with nucleotide sequence coding for vesicle transport stress-related polypeptides or resulting in gene expression of increased growth and/or increased drought resistance |